Projected 2023 Cost Reduction From Tumor Necrosis Factor α Inhibitor Biosimilars in Dermatology: A National Medicare Analysis

Cutis. 2024 Oct;114(4):E8-E11. doi: 10.12788/cutis.1107.

Authors

Katie Roster¹, Christian Gronbeck¹, Hao Feng¹

Affiliation

¹ Dr. Roster is from the Department of Dermatology, Georgetown University School of Medicine, Medstar Washington Hospital Center, Washington, DC. Drs. Gronbeck and Feng are from the Department of Dermatology, University of Connecticut Health Center, Farmington.

PMID: 39621559
DOI: 10.12788/cutis.1107

No abstract available

Publication types

Letter